Tabalumab Auto-Injector

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Lupus Erythematosus, SystemicRheumatoid Arthritis

Phase 3

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

TerminatedNCT01676701

Eli Lilly and CompanyRheumatoid Arthritis

Start: 2012-09-30End: 2013-08-31Updated: 2018-04-26

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

TerminatedNCT02041091

Eli Lilly and CompanyLupus Erythematosus, Systemic

Start: 2014-01-31End: 2015-11-30Updated: 2018-06-15